362 related articles for article (PubMed ID: 35441414)
21. High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis.
Ravi V; Poudyal A; Abid QU; Larsen T; Krishnan K; Sharma PS; Trohman RG; Huang HD
Europace; 2021 May; 23(5):710-721. PubMed ID: 33523184
[TBL] [Abstract][Full Text] [Related]
22. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
[TBL] [Abstract][Full Text] [Related]
23. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation.
Müller J; Berkovitz A; Halbfass P; Nentwich K; Ene E; Sonne K; Simu G; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Deneke T
Europace; 2022 Jul; 24(6):928-937. PubMed ID: 35134155
[TBL] [Abstract][Full Text] [Related]
24. Contact force and catheter stability are predictive metrics of successful pulmonary vein isolation with high-power short duration ablation in atrial fibrillation.
Honarbakhsh S; Martin CA; Dhillon G; Gallagher M; Sohal M; Chow A; Ahsan S; Abbass H; Whittaker-Axon S; Lambiase PD; Davies MJ; Ginks M; Hunter RJ
J Cardiovasc Electrophysiol; 2023 May; 34(5):1141-1151. PubMed ID: 36808788
[TBL] [Abstract][Full Text] [Related]
25. Comparison of lesion characteristics between conventional and high-power short-duration ablation using contact force-sensing catheter in patients with paroxysmal atrial fibrillation.
Chen CC; Lee PT; Van Ba V; Chuang CM; Lin YJ; Lo LW; Hu YF; Chung FP; Lin CY; Chang TY; Vicera JJ; Huang TC; Liu CM; Wu CI; Lugtu IC; Jain A; Chang SL; Chen SA
BMC Cardiovasc Disord; 2021 Aug; 21(1):387. PubMed ID: 34372779
[TBL] [Abstract][Full Text] [Related]
26. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint.
Scherr D; Khairy P; Miyazaki S; Aurillac-Lavignolle V; Pascale P; Wilton SB; Ramoul K; Komatsu Y; Roten L; Jadidi A; Linton N; Pedersen M; Daly M; O'Neill M; Knecht S; Weerasooriya R; Rostock T; Manninger M; Cochet H; Shah AJ; Yeim S; Denis A; Derval N; Hocini M; Sacher F; Haissaguerre M; Jais P
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):18-24. PubMed ID: 25528745
[TBL] [Abstract][Full Text] [Related]
27. Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: A retrospective single-center study.
Piringer R; Deneke T; Foldyna B; Sonne K; Nentwich K; Ene E; Barth S; Lüsebrink U; Berkovitz A; Halbfass P
J Cardiovasc Electrophysiol; 2021 Mar; 32(3):695-703. PubMed ID: 33442930
[TBL] [Abstract][Full Text] [Related]
28. Catheter ablation of persistent atrial fibrillation: anatomically based circumferential pulmonary vein ablation in combination with a potential-guided segmental approach to achieve complete pulmonary vein isolation.
Kettering K; Weig HJ; Busch M; Schneider KM; Eick C; Weretka S; Laszlo R; Gawaz M; Schreieck J
J Interv Card Electrophysiol; 2011 Jan; 30(1):63-72. PubMed ID: 21253841
[TBL] [Abstract][Full Text] [Related]
29. Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta-analysis.
Chen CF; Wu J; Jin CL; Liu MJ; Xu YZ
Clin Cardiol; 2020 Dec; 43(12):1631-1640. PubMed ID: 33107625
[TBL] [Abstract][Full Text] [Related]
30. Repeat pulmonary vein isolation with or without FIRM-guided ablation for recurrent atrial fibrillation with pulmonary vein reconnection.
Peigh G; Wasserlauf J; Kaplan RM; Amaral AP; Trivedi A; Chicos AB; Arora R; Kim S; Lin A; Verma N; Knight BP; Passman RS
J Cardiovasc Electrophysiol; 2020 May; 31(5):1031-1037. PubMed ID: 32115794
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of high power short duration in atrial fibrillation ablation - a superior efficient ablation strategy.
Xu M; Yang Y; Zhang D; Jiang W
Acta Cardiol; 2022 Feb; 77(1):14-32. PubMed ID: 34218737
[TBL] [Abstract][Full Text] [Related]
32. Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study.
Teunissen C; Kassenberg W; van der Heijden JF; Hassink RJ; van Driel VJ; Zuithoff NP; Doevendans PA; Loh P
Europace; 2016 Sep; 18(9):1335-42. PubMed ID: 26838694
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of atrial fibrillation ablation in patients with or without silent pulmonary veins from prior ablation procedure.
Aguilera J; Hutt E; Kaur S; Saliba WI; Tarakji KG; Baranowski B; Bhargava M; Kanj M; Cantillon DJ; Rickard J; Sroubek J; Nakagawa H; Wazni OM; Hussein AA
J Cardiovasc Electrophysiol; 2022 Sep; 33(9):1994-2000. PubMed ID: 35689504
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary Vein Antral Isolation and Nonpulmonary Vein Trigger Ablation Are Sufficient to Achieve Favorable Long-Term Outcomes Including Transformation to Paroxysmal Arrhythmias in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation.
Liang JJ; Elafros MA; Muser D; Pathak RK; Santangeli P; Zado ES; Frankel DS; Supple GE; Schaller RD; Deo R; Garcia FC; Lin D; Hutchinson MD; Riley MP; Callans DJ; Marchlinski FE; Dixit S
Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784738
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Durability of High- and Very High-Power Short-Duration PVI by Invasive Remapping: The HPSD Remap Study.
Szegedi N; Salló Z; Nagy VK; Osztheimer I; Hizoh I; Lakatos B; Boussoussou M; Orbán G; Boga M; Ferencz AB; Komlósi F; Tóth P; Perge P; Kovács A; Merkely B; Gellér L
Circ Arrhythm Electrophysiol; 2024 Feb; 17(2):e012402. PubMed ID: 38284286
[TBL] [Abstract][Full Text] [Related]
36. Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high-power short-duration ablation.
Iqbal AM; Li KY; Gautam S
J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1370-1376. PubMed ID: 37232420
[TBL] [Abstract][Full Text] [Related]
37. Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study.
Chen WJ; Gan CX; Cai YW; Liu YY; Xiao PL; Zou LL; Xiong QS; Qin F; Tao XX; Li R; Du HA; Liu ZZ; Yin YH; Ling ZY
BMC Med; 2023 Nov; 21(1):461. PubMed ID: 37996906
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation.
Wasmer K; Dechering DG; Köbe J; Mönnig G; Pott C; Frommeyer G; Lange PS; Kochhäuser S; Eckardt L
Clin Res Cardiol; 2016 Sep; 105(9):738-43. PubMed ID: 27048420
[TBL] [Abstract][Full Text] [Related]
39. High power short duration versus low power long duration ablation in patients with atrial fibrillation: A meta-analysis of randomized trials.
Parlavecchio A; Vetta G; Coluccia G; Pistelli L; Caminiti R; Ajello M; Magnocavallo M; Dattilo G; Foti R; Carerj S; Crea P; Chierchia GB; de Asmundis C; Della Rocca DG; Palmisano P
Pacing Clin Electrophysiol; 2023 Nov; 46(11):1430-1439. PubMed ID: 37812165
[TBL] [Abstract][Full Text] [Related]
40. Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians.
Mujović N; Marinković M; Lenarczyk R; Tilz R; Potpara TS
Adv Ther; 2017 Aug; 34(8):1897-1917. PubMed ID: 28733782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
